MAOA methylation is associated with nicotine and alcohol dependence in women
- 2 May 2008
- journal article
- research article
- Published by Wiley in American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics
- Vol. 147B (5) , 565-570
- https://doi.org/10.1002/ajmg.b.30778
Abstract
In recent years, the role of epigenetic phenomenon, such as methylation, in mediating vulnerability to behavioral illness has become increasingly appreciated. One prominent locus at which epigenetic phenomena are thought to be in play is the monoamine oxidase A (MAOA) locus. In order to examine the role of methylation at this locus, we performed quantitative methylation analysis across the promoter region of this gene in lymphoblast lines derived from 191 subjects participating in the Iowa Adoption Studies (IAS). We analyzed the resulting data with respect to genotype and lifetime symptom counts for the more common major behavioral disorders in the IAS, antisocial personality disorder (ASPD), and substance use disorders (alcohol (AD) and nicotine dependence (ND)). We found that methylation status was significantly associated with lifetime symptom counts for ND (P < 0.001) and AD (P < 0.008) in women, but not men. Furthermore, a trend was found for women homozygous for the 3,3 allele to have a higher degree of overall methylation than women homozygous for the 4,4 allele (P < 0.10). We conclude that methylation of MAOA may play a significant role in common psychiatric illness and that further examination of epigenetic processes at this locus is in order.Keywords
This publication has 38 references indexed in Scilit:
- Large-Scale Population Study of Human Cell Lines Indicates that Dosage Compensation Is Virtually CompletePLoS Genetics, 2008
- Monoamine Oxidase Inhibition for Tobacco PharmacotherapyClinical Pharmacology & Therapeutics, 2007
- The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption StudiesAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2007
- Population genomics of human gene expressionNature Genetics, 2007
- Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessationNicotine & Tobacco Research, 2007
- Transcriptional profiling of lymphoblast lines from subjects with panic disorderAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2007
- A new method for accurate assessment of DNA quality after bisulfite treatmentNucleic Acids Research, 2007
- Serotonin transporter mRNA levels are associated with the methylation of an upstream CpG islandAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2006
- Association between monoamine oxidase gene polymorphisms and smoking behaviour in Chinese malesInternational Journal of Neuropsychopharmacology, 2005
- Transcription regulation and animal diversityNature, 2003